Evidence map›Paper›PMID 29368618›Full record

ArticleGlobalization and health2018

Psychotropic drugs in Nepal: perceptions on use and supply chain management.

Nawaraj Upadhaya, Mark J D Jordans, Dristy Gurung, Ruja Pokhrel, Ramesh P Adhikari, Ivan H Komproe

Abstract read
In one paragraph

Article in Globalization and health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Assessing the Indicators of Good Pharmacy Practice in Community Pharmacies: A Cross-Sectional Study.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nawaraj UpadhayaTranscultural Psychosocial Organization Nepal, Kathmandu, Nepal. upadhayan@gmail.com.
Mark J D JordansTranscultural Psychosocial Organization Nepal, Kathmandu, Nepal.
Dristy GurungTranscultural Psychosocial Organization Nepal, Kathmandu, Nepal.
Ruja PokhrelTranscultural Psychosocial Organization Nepal, Kathmandu, Nepal.
Ramesh P AdhikariTranscultural Psychosocial Organization Nepal, Kathmandu, Nepal.
Ivan H KomproeDepartment of Research and Development, HealthNet TPO, Amsterdam, the Netherlands.

Funding

Europian Union 305968
6 · The paper itself

Abstract

backgroundPsychotropic drugs play an important role in the treatment of mental, neurological and substance use disorders. Despite the advancement of the use of psycho-pharmaceuticals in the developed countries, the psychotropic drug production and supply chain management in low- and middle- income countries are still poorly developed. This study aims to explore the perceptions of stakeholders involved in all stages of the psychotropic drug supply chain about the need, quality, availability and effectiveness of psychotropic drugs, as well as barriers to their supply chain management. The study was conducted among 65 respondents from the Kathmandu, Chitwan and Pyuthan districts, grouped into four categories: producers, promoters and distributors (N = 22), policy makers and government actors (N = 8), service providers (N = 21) and service users/family members (N = 14).

resultsThe respondents reported that psychotropic drugs, despite having side effects, are 1) needed, 2) available in major regional centers and 3) are effective for treating mental health problems. The stigma associated with mental illness, however, forces patients and family members to hide their use of psychotropic drugs. The study found that the process of psychotropic drug supply chain management is similar to other general drugs, with the exceptions of strict pre-approval process, quantity restriction (for production and import), and mandatory record keeping. Despite these regulatory provisions, respondents believed that the misuse of psychotropic drugs is widespread and companies are providing incentives to prescribers and retailers to retain their brand in the market.

conclusionsThe production and supply chain management of psychotropic drugs is influenced by the vested interests of pharmaceutical companies, prescribers and pharmacists. In the context of the government of Nepal's policy of integrating mental health into primary health care and increased consumption of psychotropic drugs in Nepal, there is a need for massive education and awareness as well as strict monitoring and supervision to avoid the misuse of psychotropic drugs.

Indexed as

Attitude to HealthHumansMental DisordersNeeds AssessmentNepalPsychotropic DrugsSocial StigmaStakeholder ParticipationPsychotropic DrugsMental healthNepalPsychotropic drugsSupply chain management

Identifiers

PMID29368618
PMCPMC5784600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.